Results 201 to 210 of about 174,470 (255)
Some of the next articles are maybe not open access.

Flow‐assisted diagnostic management of anaphylaxis from rocuronium bromide

Allergy, 2006
Background:  Diagnosis of anaphylaxis from neuromuscular blocking agents (NMBA) is not always straightforward.Objectives:  To assess flow cytometric analysis of activated basophils (BAT) as a diagnostic instrument in anaphylaxis from rocuronium. To investigate whether the technique might help to identify cross‐reactive and safe alternative compounds ...
Chris H. Bridts   +5 more
openaire   +3 more sources

Neuromuscular recovery following rocuronium bromide single dose in infants

Pediatric Anesthesia, 2004
SummaryBackground : Rocuronium bromide, a steroid nondepolarizing muscle relaxant, has a rapid onset and an intermediate duration of action in infants, children and adults. However, clinical evidence shows a longer duration of recovery in small infants.
Altenmueller Ca, Rapp Hj, Waschke C
openaire   +3 more sources

Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.

European journal of anaesthesiology. Supplement, 1994
The existing human pharmacokinetic studies have been reviewed and compared with data derived from animals. The earliest study confirms the similarity of rocuronium to vecuronium with respect to the variables derived from the plasma concentration decay curves and the proportion excreted renally.
Wierda, JMKH   +3 more
openaire   +2 more sources

Pain on Injection of Rocuronium Bromide

Anesthesia & Analgesia, 1997
Monique A H Steegers   +3 more
openaire   +3 more sources

Pain on Injection of Rocuronium Bromide

Anesthesia & Analgesia, 1995
Stephen F. Dierdorf   +1 more
openaire   +3 more sources

Pharmacokinetics of rocuronium bromide in patients with and without renal failure.

European journal of anaesthesiology. Supplement, 1995
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaesthesia with nitrous oxide, fentanyl and isoflurane after a single bolus dose of rocuronium (0.6 mg kg-1) in nine patients with chronic renal failure requiring regular haemodialysis, and in nine healthy control patients.
COOPER, RA   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy